Close

CRSP Financial Facts

See Full Income Statement

See Full Balance Sheet

CRISPR Therapeutics (CRSP) Earnings

  |   Expand Research on CRSP
Next EPS Date 4/30/24 EPS Growth Rate -116.4%
Average EPS % Beat Rate +561.2% Revenue Growth Rate -83.7%
Average % Move 1-Wk after EPS +7.6% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
4/30/24 Q124 N/A-$1.45 N/A N/A$16.32M N/A N/A N/A
2/13/24 Q423 N/A$0.23 N/A N/A$149.21M N/A N/A N/A
2/21/24 Q423 $1.10$0.05 +$1.05$201.2M$140.55M N/A Details
11/1/23 Q323 N/A-$1.99 N/A N/A$8.66M N/A N/A N/A
11/6/23 Q323 -$1.41-$1.99 +$0.58N/A$8.66M N/A Details
8/7/23 Q223 -$0.98-$2.13 +$1.15$70K$1.8M N/A Details
8/8/23 Q223 N/A-$2.13 N/A N/A$1.8M N/A N/A N/A
5/8/23 Q123 -$0.67-$1.74 +$1.07$100M$25.85M N/A Details